Algo version: 0.98b
XTLB is listed at the NASDAQ Exchange
XTLB [XTLB]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is XTLB stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for XTL Biopharmaceuticals 10 years ago, but if you had invested on Tuesday 31st of October 2023 when the price was $0.833, you would have made a profit of $0.937 per share or 112.51%

No, the average daily trading liquidity for XTL Biopharmaceuticals is $64 182 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

XTL Biopharmaceuticals has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for XTL Biopharmaceuticals to be medium [0.6 out of 1]